Answers are grounded in this paper and cite their sources.
Background Engineered nanomaterials (NMs) are widely tested for biological safety using standard colorimetric, fluorometric, and enzymatic in vitro assays. However, the unique physicochemical properties of NMs, including strong optical activity, high surface-to-volume ratios, and surface reactivity, create a high potential for systematic, often unrecognized interference with these assays. Objectives This systematic review sought to i) provide a comprehensive catalogue of reported cases of NM-induced assay interference, ii) quantify interference severity and direction by NM type and assay system, iii) synthesize reported physicochemical characteristics associated with assay interference, and iv) provide evidence-based recommendations for mitigation. Methods A systematic search of PubMed, Web of Science, and Scopus (2006-2026) identified 52 eligible records for the evidence synthesis, comprising primary experimental or method-validation studies together with contextual evidence. Data were extracted on NM composition, size, surface chemistry, assay type, interference mechanism, and effect magnitude. Interference severity was scored semi-quantitatively (0–3). A systematic narrative synthesis was performed. Results Interference was documented across multiple nanomaterial categories and assay platforms represented in the evidence matrix, with the extent of evidence varying among individual nanomaterial–assay combinations. Carbon-based nanomaterials demonstrated interference across several commonly used viability assays, although the concentrations and experimental conditions associated with interference varied substantially among studies. Silver NPs exhibited a strong LDH interference due to protein adsorption and ROS-mediated deactivation. The iron oxide NPs showed concentration-dependent optical interference across the experimental spectral ranges examined in the contributing studies. Cytokine ELISA tests were vulnerable to cytokine sequestration by TiO 2 , SiO 2 and cationic NPs. Consistent with prior population-level literature surveys, not restricted to this review’s eligibility-filtered cohort, the proportion of nanotoxicology publications omitting interference controls has been reported to fall from over 90% before 2014 to approximately 45% by 2021–2024, underscoring the reporting gap that motivated this review’s interference-control eligibility criterion. Conclusion NM-induced assay interference is pervasive, NM-specific, assay-specific, and concentration-dependent. No universal correction exists; each NM–assay combination requires individual validation. A standardized five-step interference testing workflow and reporting checklist are proposed to improve reproducibility in nanotoxicology.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: